Available Technologies

Results

2-Aminoindole-Class Antimalarials

Technology / Case number: #14097BJ
Ralph Mazitschek / Sameer Urgaonkar / Cassandra Celatka / Dyann Wirth / Roger Wiegand / Mary Lynn Baniecki / Joseph Cortese / Edmund Sybertz / Renato Skerlj / Yibin Xiang / Elyse Bourque / Jon Clardy
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

A Novel Injectable Thiol-Acrylate Poly(ethylene Glycol) Hydrogel for Sustained Release of Methylprednisolone Sodium Succinate

Technology / Case number: #14439J
Eric Woodard / Christopher Pritchard / Daniel Siegwart / Timothy O'Shea / Francis Reynolds / Jonathan Slotkin / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Engineered Probiotics for Urinary Cancer Diagnosis

Technology / Case number: #15881HJ
Tal Danino / Arthur Prindle / Jeff Hasty / Sangeeta Bhatia
Technology Areas: Biomaterials & Bioelectronics / Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Diminished Proteolytic Shedding of Receptor Tyrosine Kinases Mediates MEK Inhibitor Resistance in Triple-Negative Breast Cancer

Technology / Case number: #16742
Aaron Meyer / Miles Miller / Madeleine Oudin / Linda Griffith / Douglas Lauffenburger / Frank Gertler
Technology Areas: Therapeutics
Impact Areas: Healthy Living
Labels
  • Women's Health
License

Generation of Specialized, High-Value Cells and Tissues from Human Induced Pluripotent Stem Cells by Recapitulating Early Embryogenesis Using Gata Factor-Induced Endoderm

Technology, Tangible Property / Case number: #16205
Ron Weiss / Patrick Guye / Mohammad Reza Ebrahimkhani
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Covalently Functionalized Hydrogels on Oxygen Permeable Membranes for Stable, Scalable, and Xeno Free Growth of Undifferentiated Human Embryonic Stem Cells

Technology / Case number: #16162
Anna Coclite / Amanda Diienno / Karen Gleason / Clark Colton
Technology Areas: Biotechnology / Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

A Novel Method to Treat Myocardial Infarction and Other Tissue Damage Using Apolipoprotein D (apoD)

Technology / Case number: #15466
Kosuke Tsukamoto / Monty Krieger
Technology Areas: Biomaterials & Bioelectronics / Therapeutics
Impact Areas: Healthy Living
License

Improved Treatment for Organ Regeneration and Blocking Scar Formation

Technology / Case number: #25302
Ioannis Yannas
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

The technologies listed represent a selection of the MIT intellectual property protected by the TLO.

filtered: 8 results

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.